US9585868 — Methods and compositions for treating HIV-associated diarrhea
Method of Use · Assigned to Napo Pharmaceuticals Inc · Expires 2031-10-31 · 5y remaining
What this patent protects
This patent protects methods for treating diarrhea, including HIV-associated diarrhea, by administering an inhibitor of chloride-ion transport, such as crofelemer.
USPTO Abstract
Presented herein are methods for treating diarrhea by administering to a patient in need thereof, an inhibitor of chloride-ion transport in an amount sufficient to treat diarrhea. Treatment of diarrhea includes the treatment of the diarrhea as well as the pain, abdominal discomfort and other symptoms associated with diarrhea. In one embodiment, the inhibitor of chloride-ion transport is crofelemer.
Drugs covered by this patent
- Mytesi (CROFELEMER) · Napo Pharms Inc
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1319 |
— | Mytesi |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.